In another retrospective study from two UK reference centers evaluating patients with SPAs (17% with positive staining for ACTH) who presented with tumor regrowth after primary treatment, the anterior pituitary hormone immunostaining profile of the adenoma was not a substantial factor for further tumor regrowth (92). Here, POMC is linked to neoplasm.